PIROLA, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 5.961
EU - Europa 2.975
AS - Asia 2.380
SA - Sud America 371
AF - Africa 45
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 11.744
Nazione #
US - Stati Uniti d'America 5.810
SG - Singapore 949
CN - Cina 667
DE - Germania 640
IT - Italia 496
RU - Federazione Russa 405
SE - Svezia 398
IE - Irlanda 322
BR - Brasile 307
HK - Hong Kong 299
UA - Ucraina 194
GB - Regno Unito 185
VN - Vietnam 165
CA - Canada 114
FR - Francia 91
IN - India 70
FI - Finlandia 69
TR - Turchia 48
DK - Danimarca 34
ID - Indonesia 32
BE - Belgio 31
AR - Argentina 27
JP - Giappone 27
BD - Bangladesh 25
PL - Polonia 25
MX - Messico 24
ZA - Sudafrica 24
NL - Olanda 19
ES - Italia 18
IQ - Iraq 17
KR - Corea 15
AT - Austria 14
CO - Colombia 10
LT - Lituania 10
IR - Iran 9
PK - Pakistan 9
EC - Ecuador 7
EU - Europa 7
KE - Kenya 7
SA - Arabia Saudita 7
CH - Svizzera 6
JO - Giordania 6
PY - Paraguay 6
CZ - Repubblica Ceca 5
PE - Perù 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
IL - Israele 4
VE - Venezuela 4
AU - Australia 3
DO - Repubblica Dominicana 3
MA - Marocco 3
MY - Malesia 3
NP - Nepal 3
RO - Romania 3
AM - Armenia 2
BG - Bulgaria 2
CL - Cile 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
LV - Lettonia 2
MU - Mauritius 2
PS - Palestinian Territory 2
SC - Seychelles 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BM - Bermuda 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
LB - Libano 1
LK - Sri Lanka 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TO - Tonga 1
TW - Taiwan 1
Totale 11.744
Città #
Ann Arbor 1.069
Singapore 585
Ashburn 562
Woodbridge 418
Fairfield 378
Houston 351
Chandler 347
Frankfurt am Main 335
Dublin 312
Hong Kong 299
Wilmington 250
Milan 239
Dearborn 225
Jacksonville 177
Seattle 170
New York 149
Beijing 134
Cambridge 123
Los Angeles 111
Santa Clara 98
Princeton 86
Dallas 73
Nanjing 65
Göttingen 61
Shanghai 57
Munich 46
Ho Chi Minh City 40
Buffalo 38
Altamura 37
Lawrence 36
São Paulo 36
Moscow 35
Hefei 32
Brussels 31
Hanoi 30
The Dalles 30
Jakarta 29
Lachine 29
Boardman 28
Ottawa 28
Nanchang 26
Chicago 25
Shenyang 25
Dong Ket 23
Guangzhou 22
San Diego 22
Fürstenwalde 21
Helsinki 21
Andover 19
Fremont 19
Kocaeli 19
London 18
Falls Church 17
Montreal 17
Toronto 17
Hebei 16
Johannesburg 16
Warsaw 16
Council Bluffs 15
Tianjin 15
Tokyo 15
Chennai 14
Nuremberg 14
Orem 14
Stockholm 14
Changsha 13
Lissone 13
Brooklyn 12
Jiaxing 12
Jinan 12
Kunming 12
Manchester 12
Phoenix 12
Boston 11
Edmonton 11
Norwalk 11
Pune 11
Seoul 11
Atlanta 10
Denver 10
Lauterbourg 10
Mexico City 10
Mumbai 10
Pavia 10
Salt Lake City 10
Ankara 9
Brasília 9
Charlotte 9
Chengdu 9
Düsseldorf 9
Romola 9
Turku 9
Kent 8
Kiev 8
Nürnberg 8
Poplar 8
Rio de Janeiro 8
Da Nang 7
Redmond 7
Rome 7
Totale 7.986
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 509
A bioinformatics procedure to identify and annotate somatic mutations in whole-exome sequencing data 444
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 397
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 391
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 380
The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis 355
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 355
WHOLE-EXOME SEQUENCING OF A PHILADELPHIA NEGATIVE CHRONIC MYELOID LEUKEMIA PATIENT THROUGH THE EXON-CAPTURE TECHNIQUE 352
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 349
A computational procedure to identify and annotate somatic mutations in next-generation sequencing data 346
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 345
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma 314
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 310
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 305
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 303
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells 297
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 275
Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia 271
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 271
Whole-Exome Sequencing Data - Identifying Somatic Mutations 270
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma 265
Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients 259
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis 252
Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma 251
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 248
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 245
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 245
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 236
CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis 233
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 227
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 224
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib 220
Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients 219
Whole-exome sequencing of matched chronic phase and blast crisis CML samples to reveal mechanisms of blast crisis transformation 217
Identification of Novel Point Mutations in Splicing Sites by the Integration of Exome and RNA Sequencing Data in Myeloproliferative Diseases 216
BCR AND BCR-ABL REGULATION DURING MYELOID DIFFERENTIATION IN HEALTHY DONORS AND CHRONIC PHASE-BLAST CRISIS CML PATIENTS 202
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922 196
Abstract 3583: Drug-resistant NPM/ALK mutants show different sensitivity to second generation tyrosine kinase inhibitors 194
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia 193
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 187
Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma 180
Erratum: Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma (Molecular Cancer Research (2015) 13 (775-783)) 160
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients 156
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo 155
Mechanisms of resistance to the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma cells 118
Totale 12.137
Categoria #
all - tutte 37.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021818 0 0 0 0 0 116 145 130 106 134 82 105
2021/2022637 47 70 75 52 32 61 36 33 33 64 51 83
2022/20231.330 143 400 129 128 104 196 12 76 79 17 28 18
2023/2024886 27 35 34 53 110 270 176 12 49 25 8 87
2024/20251.919 135 166 120 97 194 74 113 72 164 360 161 263
2025/20262.484 610 209 387 595 622 61 0 0 0 0 0 0
Totale 12.137